← Open Payments lookup

SAKILA RAI: Open Payments

NPI 1285408799 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$281 in 12 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $140 · 2025 $281

Food & beverage: $281
CompanyPaymentsAmount
Deciphera Pharmaceuticals Inc.2$55
Regeneron Healthcare Solutions, Inc.2$51
Exelixis Inc.2$38
Syndax Pharmaceuticals, Inc.1$33
PFIZER INC.1$23
Astellas Pharma US Inc1$22
Karyopharm Therapeutics Inc.1$21
Novartis Pharmaceuticals Corporation1$20
Merck Sharp & Dohme LLC1$19

Products named: QINLOCK, LIBTAYO, CABOMETYX, INLYTA, Xtandi, XPOVIO, PLUVICTO, KEYTRUDA.

Industry payments across TX — which companies pay providers there.